Research & Development
The Burzynski Research Institute is focused on the research and development of antineoplastons for the treatment of various malignancies. Antineoplastons are molecules that cause cytostasis (stop cancer cell growth) and apoptosis (cell death) by targeting multiple cellular pathways which cause cancer cells to grow uncontrollably. Some of these pathways include, DNA synthesis, cell cycle, Glycolysis, Tricarboxylic acid cycle (TCA), Survivin etc.
|
